Glyburide and Increased bronchial secretion - a phase IV clinical study of FDA data

Summary:

Increased bronchial secretion is reported as a side effect among people who take Glyburide (glyburide), especially for people who are female, 60+ old, also take Novorapid, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Increased bronchial secretion when taking Glyburide. It is created by eHealthMe based on reports of 37,840 people who have side effects when taking Glyburide from the FDA, and is updated regularly.

What is Glyburide?

Glyburide has active ingredients of glyburide. It is often used in diabetes. eHealthMe is studying from 38,448 Glyburide users. Check the latest studies of Glyburide.

What is Increased bronchial secretion?

Increased bronchial secretion is found to be associated with 370 drugs and 411 conditions by eHealthMe. Check the latest studies of Increased bronchial secretion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

37,840 people reported to have side effects when taking Glyburide.
Among them, 12 people (0.03%) have Increased bronchial secretion.

Could Glyburide cause Increased bronchial secretion?

Among these 12 people:

What is the gender of people who have Increased bronchial secretion when taking Glyburide? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Increased bronchial secretion when taking Glyburide? *

What are other drugs people take besides Glyburide? *

What are other side effects people have besides Increased bronchial secretion? *

Abdominal Discomfort: 10 people, 83.33%
Dyspnea (difficult or laboured breathing): 10 people, 83.33%
Impaired Gastric Emptying: 10 people, 83.33%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 83.33%
Nausea (feeling of having an urge to vomit): 10 people, 83.33%
Paleness (unusual lightness of skin colour): 9 people, 75.00%
Body Temperature Increased: 9 people, 75.00%
Catheter Site Infection (infection at the site of insertion): 9 people, 75.00%
Chest Injury: 9 people, 75.00%
Chest Pain: 9 people, 75.00%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 83.33%

* Approximation only. Some reports may have incomplete information.

Do you take Glyburide and have Increased bronchial secretion?

- Check whether Increased bronchial secretion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glyburide:

Glyburide (38,448 reports)

Browse all side effects of Glyburide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Increased bronchial secretion:

Increased bronchial secretion (370 drugs)

Browse all the conditions that are associated with Increased bronchial secretion:

Increased bronchial secretion (411 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glyburide (the active ingredients of Glyburide) and Glyburide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.